People · Operator
Named in public records as an officer, director or promoter · active 2016–2025 · Biotechnology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Inspirna, Inc. | — | Biotechnology | Series C | $141.9M | $1.1B | 2022 |
| FORE US Bio Inc. | — | Biotechnology | Series C | $99.5M | $243.5M | 2023 |
| Coya Therapeutics, Inc. | — | Biotechnology | Series B | $56.9M | $62.4M | 2023 |
| HealthPrize Technologies, LLC | — | Healthtech | Seed | $14.4M | $83.1M | 2016 |
Dieter Weinand at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dieter Weinand on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jack Nielsen | 1 | 13 |
| David Rector | 1 | 11 |
| Erez Chimovits | 1 | 7 |
| Michal Silverberg | 1 | 7 |
| Kevin Jones | 1 | 6 |
| ANTOINE PAPIERNIK | 1 | 6 |
| Dov Goldstein | 1 | 6 |
| David Snyder | 1 | 5 |
| Raymond Camahort | 1 | 4 |
| Eric Rowinsky | 1 | 4 |
| Nilesh Kumar | 1 | 4 |
| Dawn Owens | 1 | 4 |
| Robert Dahl | 1 | 4 |
| Nancy Chang | 1 | 4 |
| MICHAEL A. GRIFFITH | 1 | 3 |
| Robert Kamerschen | 1 | 3 |
| Shawn M Titcomb | 1 | 3 |
| Shahram Seyedin-Noor | 1 | 3 |
| Kim Blackwell | 1 | 3 |
| Chandra Leo | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.